Skip to content
Search for:
Search
Cancer Matters
Investigating the latest headlines, pharma news and research in cancer
Home
In the news
Research
Pharma
Opinions
About
Tag:
Zejula
1 Post
Pharma
FDA OKs Tesaro’s Zejula in recurrent ovarian cancer
March 29, 2017
—
0 Comments
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here:
Cookie Policy
Subscribe
Subscribed
Cancer Matters
Sign me up
Already have a WordPress.com account?
Log in now.
Cancer Matters
Customize
Subscribe
Subscribed
Sign up
Log in
Report this content
View site in Reader
Manage subscriptions
Collapse this bar
Cancer Matters 